Colorectal News and Research

RSS

High-intensity exercise may reduce colorectal cancer risk in Lynch Syndrome patients

Regular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome (LS) by improving the immune system's ability to detect and remove potentially harmful cells, according to researchers at The University of Texas MD Anderson Cancer Center.

19 Sep 2023

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

A recent review in the journal Immunity delves into the crucial role of dendritic cells (DCs) in shaping T-cell responses in cancer, highlighting their importance in both priming anti-tumor immunity and in ongoing immune interactions within tumors. The findings underscore the potential of DCs as key targets for next-generation cancer immunotherapies.

18 Sep 2023

Breast milk proteins linked to abundance of beneficial bacteria in infants

More than 320 million years of mammalian evolution has adapted breast milk to meet all the physiological needs of babies: it contains not only nutrients, but also hormones, antimicrobials, digestive enzymes, and growth factors.

15 Sep 2023

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

Scientists explore the myriad benefits of maple syrup, revealing its nutritional, pharmacological, and sensory advantages over traditional sweeteners. From antioxidant and anti-inflammatory properties to controlling blood sugar and even potential anticancer effects, maple syrup is more than just a tasty topping.

14 Sep 2023

How does the APOE4 gene play both hero and villain in your health risks?

The study reveals that APOE4, a genetic risk factor for Alzheimer's Disease and cardiovascular diseases, has complex effects on mortality risk. While APOE4 carriers with higher AD neuropathology have increased mortality risk, those with low neuropathology had a reduced risk of certain cancers, warranting further research into this genetic factor's diverse impact on health outcomes.

14 Sep 2023

Specialized gut immune cells could be new biomarker for IBD progression

Researchers at the Francis Crick Institute, King's College London and Guy's and St Thomas' NHS Foundation Trust have characterised a specialised type of immune cell, which plays a key role in protecting and repairing the cells in the healthy human gut.

14 Sep 2023

MIT study reveals why immunotherapy doesn't work for all cancer patients

This block is broken or missing. You may be missing content or you might need to enable the original module.

14 Sep 2023

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Today, the American Association for Cancer Research (AACR) released the 13th edition of its annual Cancer Progress Report, which chronicles how basic, translational, and clinical cancer research and cancer-related population sciences-;primarily supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI)-;remain vitally important to improving health and saving lives.

13 Sep 2023

New machine-learning algorithms can help optimize the next-generation of therapeutic antibodies

Antibody treatments may be able to activate the immune system to fight diseases like Parkinson’s, Alzheimer’s and colorectal cancer, but they are less effective when they bind with themselves and other molecules that aren’t markers of disease.

11 Sep 2023

Promising new cervical cancer test fills in the gap missed by Pap tests

Researchers assessed a novel human papillomavirus (HPV) and host deoxyribonucleic acid (DNA) methylation score for adenocarcinoma in-situ (AIS) and cervical adenocarcinoma (ADC) screening.

8 Sep 2023

Is there an association between the COVID-19 pandemic and cancer incidence?

The COVID-19 pandemic influenced cancer incidence.

8 Sep 2023

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

An international study published in BMJ Oncology analyzes the Global Burden of Disease 2019 dataset to explore the rising incidence and mortality rates of early-onset cancers (ages 14-49) worldwide. The study highlights varying cancer burdens by gender and region, identifies lifestyle and environmental risk factors, and predicts a significant increase in early-onset cancer rates by 2030.

7 Sep 2023

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

The COVID-19 pandemic led to a notable decline in new cancer diagnoses in Manitoba, Canada, particularly affecting breast, colon, and rectal cancers. The study highlights the urgent need for healthcare strategies to mitigate the impact of future disruptions on cancer detection and treatment.

6 Sep 2023

Statins may protect IBD patients from colorectal cancer, study finds

Cholesterol-lowering statins might protect patients with ulcerative colitis from developing and dying from colorectal cancer.

1 Sep 2023

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the full approval of LUMAKRAS® (sotorasib) for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer (NSCLC) at a meeting on Oct. 5, 2023.

From AMGEN 1 Sep 2023

New liquid biopsy technology uses RNA "dark matter" to detect cancer

Cancer is most treatable in its early stages, so finding innovative and non-invasive methods to diagnose cancer early on is crucial for fighting the disease.

31 Aug 2023

The Clinical Importance of Circulating Tumor DNA

Cancer remains a leading killer among medical causes of death worldwide.

31 Aug 2023

Innovative insights into effects of hematopoietic changes on colon cancer, unveiling therapeutic avenues

Researchers investigated whether bone marrow-derived cells contribute to colitis-associated colon cancer.

29 Aug 2023

A comprehensive online resource allows for the exploration of interactions between mutational signatures and topographical features across human cancer

An online resource for studying the relationship between mutational signatures and topographical characteristics across human cancer.

28 Aug 2023

Can vitamins really fight cancer? New study uncovers surprising links between micronutrients and cancer risk

The study uses Mendelian randomization to examine the relationship between 14 micronutrients and 22 cancer outcomes, finding significant associations between higher magnesium and vitamin B12 levels and increased risks of breast and colorectal cancers, respectively.

27 Aug 2023

Colorectal News and Research

High-intensity exercise may reduce colorectal cancer risk in Lynch Syndrome patients

Unlocking the secret soldiers: How dendritic cells could revolutionize cancer immunotherapy

Breast milk proteins linked to abundance of beneficial bacteria in infants

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

How does the APOE4 gene play both hero and villain in your health risks?

Specialized gut immune cells could be new biomarker for IBD progression

MIT study reveals why immunotherapy doesn't work for all cancer patients

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

New machine-learning algorithms can help optimize the next-generation of therapeutic antibodies

Promising new cervical cancer test fills in the gap missed by Pap tests

Is there an association between the COVID-19 pandemic and cancer incidence?

Rising tide of early-onset cancers: Study predicts alarming increase by 2030

COVID-19 pandemic disrupted cancer diagnoses, raising alarms for future healthcare resilience

Statins may protect IBD patients from colorectal cancer, study finds

Amgen to discuss application for LUMAKRAS® (sotorasib) for the treatment of KRAS G12C-positive NSCLC at FDA advisory committee meeting

New liquid biopsy technology uses RNA "dark matter" to detect cancer

The Clinical Importance of Circulating Tumor DNA

Innovative insights into effects of hematopoietic changes on colon cancer, unveiling therapeutic avenues

A comprehensive online resource allows for the exploration of interactions between mutational signatures and topographical features across human cancer

Can vitamins really fight cancer? New study uncovers surprising links between micronutrients and cancer risk

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News